NRIX - Nurix Therapeutics Inc
15.9
0.400 2.516%
Share volume: 1,040,556
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$15.50
0.40
0.03%
Summary score
41%
Profitability
39%
Dept financing
24%
Liquidity
58%
Performance
42%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-15.11%
Return on assets
-11.27%
Return on sales
-421.95%
Return on invested capital
6.18%
Total debt ratio
28.29%
Debt ratio change over timeo
-1.14%
Current Ratio
5%
Quick Ratio
4.37%
Cash Position Ratio
2.71%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-11.99%
Return on sales
-555.01%
Return on invested capital
0%
Total debt ratio
24.15%
Debt ratio change over timeo
0%
Current Ratio
6.36%
Quick Ratio
0%
Cash Position Ratio
1.44%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-12.08%
Return on sales
-612.03%
Return on invested capital
0%
Total debt ratio
21.71%
Debt ratio change over time
0%
Current Ratio
7.02%
Quick Ratio
0%
Cash Position Ratio
2.86%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-88.95%
Return on assets
-95.3%
Return on sales
129.58%
Return on invested capital
59.13%
Total debt ratio
-113.78%
Debt ratio change over time
-1.14%
Current Ratio
-2.93%
Quick Ratio
-4.01%
Cash Position Ratio
-2.88%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | NRIX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | -15.11% | 12.23% | 10.41% | 0% |
| Return on assets | -11.27% | 4.74% | 3.19% | 1.73% |
| Return on sales | -421.95% | 30.88% | 25.28% | 24.06% |
| Return on invested capital | 6.18% | 8.04% | 10.95% | 0% |
| Profitability | 14% | 93% | 84% | 29% |
| Total debt ratio | 28.29% | 80.37% | 59.38% | 94.09% |
| Debt ratio change over time | -1.14% | -20.57% | -85.61% | 17.33% |
| Dept financing | 8% | 21% | 16% | 50% |
| Current Ratio | 6.36% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 0% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 1.44% | 0.16% | 0.44% | 0.14% |
| Liquididy | 75% | 13% | 16% | 10% |
| Short-term ratios | NRIX | LLY | JNJ | ABBV |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -11.99% | 6.06% | 4.18% | 1.7% |
| Return on sales | -555.01% | 39.61% | 26.91% | 24.78% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 50% | 34% | 23% |
| Total debt ratio | 24.15% | 80% | 59.26% | 100.88% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 31% | 20% | 15% | 25% |
| Current Ratio | 6.36% | 1.44% | 1.09% | 0.72% |
| Quick Ratio | 0% | 1.12% | 0.84% | 0.6% |
| Cash Position Ratio | 1.44% | 0.16% | 0.44% | 0.14% |
| Liquididy | 50% | 33% | 31% | 19% |